ID
13713
Description
Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C; ODM derived from: https://clinicaltrials.gov/show/NCT01447394
Link
https://clinicaltrials.gov/show/NCT01447394
Keywords
Versions (1)
- 2/29/16 2/29/16 -
Uploaded on
February 29, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hepatitis C Virus (HCV) NCT01447394
Eligibility Hepatitis C Virus (HCV) NCT01447394
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
infection hepatitis c
Data type
boolean
Alias
- UMLS CUI [1,1]
- C3714514
- UMLS CUI [1,2]
- C0220847
Description
Hepatitis B surface antigen positive; serum HIV antibody test; screening
Data type
boolean
Alias
- UMLS CUI [1]
- C0149709
- UMLS CUI [2]
- C2229753
- UMLS CUI [3]
- C0220908
Description
liver disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0023895
Description
Substance Use Disorder
Data type
boolean
Alias
- UMLS CUI [1]
- C0038586
Description
growth factors hematologic
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0018284
- UMLS CUI [1,2]
- C0205488
Description
decompensated cirrhosis; biopsy
Data type
boolean
Alias
- UMLS CUI [1]
- C1619727
- UMLS CUI [2]
- C0005558
Similar models
Eligibility Hepatitis C Virus (HCV) NCT01447394
- StudyEvent: Eligibility
C0023890 (UMLS CUI [2])
C0432488 (UMLS CUI [3])
C0019196 (UMLS CUI [1,2])
C0220847 (UMLS CUI [1,2])
C2229753 (UMLS CUI [2])
C0220908 (UMLS CUI [3])
C0205488 (UMLS CUI [1,2])
C0005558 (UMLS CUI [2])